Product Information
ENALAPRIL MALEATE 2.5 MG TAB is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.0625 per EA under NDC 51672403703. Its NADAC has been published 598 times since Apr 1, 2015.
FDA first approved this application on Jan 23, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672403703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA075657FDA Approved
1/23/2001
TE Code
AB
On Market Since
1/23/2001
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL MALEATE 2.5 MG TAB has been published 598 times since Apr 1, 2015, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0625 per EA |
|---|---|
| All-time high | $0.2851 (Sep 14, 2016) |
| All-time low | $0.0485 (Nov 20, 2024) |
| 52-week high | $0.0747 |
| 52-week low | $0.0604 |
| Median price | $0.1437 |
| Average price | $0.1455 |
| Largest weekly change | +78.1% (Aug 21, 2024) |
| Weeks tracked | 598 |
| Tracking since | Apr 1, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enalapril Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL MALEATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 2.5 MG TAB, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.0625 per EA (NDC 51672403703), effective Sep 30, 2026.
How has the price of ENALAPRIL MALEATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for ENALAPRIL MALEATE 2.5 MG TAB has declined 78.0%. It has been tracked across 598 weekly CMS publications since Apr 1, 2015.
What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 2.5 MG TAB?
Since Apr 1, 2015, the NADAC for ENALAPRIL MALEATE 2.5 MG TAB has ranged from a low of $0.0485 (Nov 20, 2024) to a high of $0.2851 (Sep 14, 2016), with a median of $0.1437 per EA.
Are there cheaper alternatives to ENALAPRIL MALEATE 2.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL MALEATE 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ENALAPRIL MALEATE 2.5 MG TAB?
ENALAPRIL MALEATE 2.5 MG TAB (NDC 51672403703) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.